First Time Loading...

DarioHealth Corp
NASDAQ:DRIO

Watchlist Manager
DarioHealth Corp Logo
DarioHealth Corp
NASDAQ:DRIO
Watchlist
Price: 1.63 USD 1.87% Market Closed
Updated: May 8, 2024
Section:
 

Wall Street
Price Targets

DRIO Price Targets Summary
DarioHealth Corp

Wall Street analysts forecast DRIO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DRIO is 5.78 USD with a low forecast of 4.04 USD and a high forecast of 8.4 USD.

DRIO Lowest Forecast
Wall Street Target
4.04 USD
148% Upside
DRIO Average Forecast
Wall Street Target
5.78 USD
255% Upside
DRIO Highest Forecast
Wall Street Target
8.4 USD
415% Upside
Lowest
Price Target
4.04 USD
148% Upside
Average
Price Target
5.78 USD
255% Upside
Highest
Price Target
8.4 USD
415% Upside
DarioHealth Corp Competitors:
Price Targets
688271
Shanghai United Imaging Healthcare Co Ltd
18% Upside
ELN
El En SpA
6% Upside
GKOS
Glaukos Corp
1% Upside
AMBU B
Ambu A/S
6% Upside
688271
Shanghai United Imaging Healthcare Co Ltd
18% Upside
ELN
El En SpA
6% Upside
GKOS
Glaukos Corp
1% Upside
AMBU B
Ambu A/S
6% Upside
A
688617
APT Medical Inc
5% Downside
MDT
Medtronic PLC
17% Upside
688389
Shenzhen Lifotronic Technology Co Ltd
51% Upside
STE
STERIS plc
15% Upside

Revenue
Forecast

Revenue Estimate
DarioHealth Corp

For the last 8 years the compound annual growth rate for DarioHealth Corp's revenue is 49%. The projected CAGR for the next 3 years is 55%.

49%
Past Growth
55%
Estimated Growth
Estimates Accuracy
-4%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
DarioHealth Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
DarioHealth Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-84%
Average Miss
What are analyst estimates?

See Also

Summary
DRIO intrinsic value, competitors valuation, and company profile.
DCF Valuation
DRIO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DRIO stock valuation using valuation multiples.
Wall Street Estimates
DRIO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DRIO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DRIO's stock price target?
Price Target
5.78 USD

According to Wall Street analysts, the average 1-year price target for DRIO is 5.78 USD with a low forecast of 4.04 USD and a high forecast of 8.4 USD.

What is DarioHealth Corp's Revenue forecast?
Projected CAGR
55%

For the last 8 years the compound annual growth rate for DarioHealth Corp's revenue is 49%. The projected CAGR for the next 3 years is 55%.

ALPHA SPREAD
Join more than 135,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.